New Chiral Ebselen Analogues with Antioxidant and Cytotoxic Potential-Reference-Cited by-同舟云学术

New Chiral Ebselen Analogues with Antioxidant and Cytotoxic Potential

Published:2017-03-20 Issue:3 Volume:22 Page:492
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Pacuła Agata J.,Kaczor Katarzyna B.,Antosiewicz Jędrzej,Janecka Anna,Długosz Angelika,Janecki Tomasz,Wojtczak Andrzej,Ścianowski Jacek^ORCID

Funder

Narodowe Centrum Nauki

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/22/3/492/pdf

Reference46 articles.

1. The early research and development of ebselen

2. Biological and Biochemical Aspects of Selenium Compounds;Bhujan,2012

3. Ebselen exhibits glycation-inhibiting properties and protects against osmotic fragility of human erythrocytes in vitro

4. Ebselen pretreatment attenuates ischemia/reperfusion injury and prevents hyperglycemia by improving hepatic insulin signaling and β-cell survival in gerbils

5. Glutathione Peroxidase Mimic Ebselen Improves Glucose-Stimulated Insulin Secretion in Murine Islets

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selenoacetylenes Protect against Beta-Amyloid Peptide-Induced Paralysis and Promote Longevity in Caenorhabditis elegans;Journal of the Brazilian Chemical Society;2025

2. Study of Chalcogen Aspirin Derivatives with Carbonic Anhydrase Inhibitory Properties for Treating Inflammatory Pain;ACS Medicinal Chemistry Letters;2024-08-14

3. New insights in the mechanism of the SARS-CoV-2 Mpro inhibition by benzisoselenazolones and diselenides;2024-03-28

4. N-3-Methylbutyl-benzisoselenazol-3(2H)-one Exerts Antifungal Activity In Vitro and in a Mouse Model of Vulvovaginal Candidiasis;Current Issues in Molecular Biology;2024-03-14

5. Synthesis of New Chiral β-Carbonyl Selenides with Antioxidant and Anticancer Activity Evaluation—Part I;Materials;2024-02-15